Skip to main content

Table 2 Univariable and multivariable analysis for patients before matching

From: Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study

Parameters

Univariable analysis

Multivariable analysis

HR

95% CI

P value

HR

95% CI

P value

Gender Female vs. Male

1.156

0.770–1.737

0.485

   

Age < 60 years vs. ≥ 60 years

1.165

0.748–1.813

0.499

   

Smoking No vs. Yes

1.197

0.769–1.863

0.426

   

Alcoholism No vs. Yes

1.691

1.110–2.577

0.015

1.482

0.963–2.281

0.074

ASA class II vs. III

0.982

0.601–1.605

0.943

   

Hypertension No vs. Yes

0.777

0.491–1.230

0.282

   

Diabetes mellitus No vs. Yes

1.145

0.661–1.984

0.628

   

CAD No vs. Yes

0.668

0.310–1.440

0.303

   

Hepatitis No vs. Yes

2.187

0.693–6.903

0.182

   

CEA < 5 ng/ml vs. ≥ 5 ng/ml

2.372

1.599–3.519

< 0.001

1.830

1.196–2.800

0.005

CA19–9 <37 U/ml vs. ≥37 U/ml

2.259

1.406–3.629

0.001

1.327

0.793–2.222

0.281

Albumin<40 g/dl vs. ≥ 40 g/dl

0.947

0.633–1.417

0.790

   

HGB <110 g/L vs. ≥110 g/L

1.475

0.874.485

0.536

   

Occult blood No vs. Yes

1.013

0.671–1.530

0.950

   

Operation time < 3 h vs. ≥ 3 h

0.894

0.603–1.325

0.576

   

Perioperative blood transfusion No vs. Yes

1.047

0.665–1.647

0.844

   

Tumor location Right-sided vs. Left-sided

0.900

0.475–1.706

0.746

   

Defunctioning stoma No vs. Yes

0.915

0.128–6.561

0.930

   

Postoperative complication Absent vs. Present

2.312

1.485–3.599

< 0.001

1.589

0.978–2.582

0.061

Differentiation Well/Moderate vs. Poor

2.442

1.617–3.688

< 0.001

1.698

1.083–2.663

0.021

Signet-ring cell component Absent vs. Present

6.603

2.082–20.938

0.001

1.821

0.522–6.349

0.347

Mucin No vs. Yes

1.226

0.750–2.002

0.416

   

PNI Yes vs. No

3.712

2.108–6.538

< 0.001

2.389

1.314–4.344

0.004

LVI Yes vs. No

2.709

1.720–4.266

< 0.001

1.600

0.977–2.619

0.062

T stage 1/2 vs. 3/4

2.809

1.568–5.034

0.001

1.417

0.757–2.655

0.276

N stage 0 vs. 1/2

2.905

1.875–4.500

< 0.001

1.704

1.048–2.771

0.032

TNM I/II vs. III

3.829

2.230–6.576

< 0.001

1.704

1.048–2.771

0.032

  1. ASA American Society of Anesthesiologists, CAD coronary artery disease, CEA carcinoembryonic antigen, CA19–9 carbohydrate antigen 19–9, HGB hemoglobin, TNM tumor-lymph node-metastasis, LVI lymphovascular invasion, PNI perineural invasion